Alcon (ALC) Stock Overview
Researches, develops, manufactures, distributes, and sells eye care products worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for ALC from our risk checks.
ALC Community Fair Values
Create NarrativeSee what 25 others think this stock is worth. Follow their fair value or set your own to get alerts.
Alcon Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 62.88 |
| 52 Week High | CHF 87.00 |
| 52 Week Low | CHF 57.68 |
| Beta | 0.69 |
| 1 Month Change | 6.79% |
| 3 Month Change | -10.86% |
| 1 Year Change | -17.76% |
| 3 Year Change | 1.85% |
| 5 Year Change | 9.55% |
| Change since IPO | 8.32% |
Recent News & Updates
Recent updates
Alcon Inc. (VTX:ALC) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Nov 14
Is Now The Time To Put Alcon (VTX:ALC) On Your Watchlist?
Aug 14Earnings Tell The Story For Alcon Inc. (VTX:ALC)
Jul 02Alcon (VTX:ALC) Strong Profits May Be Masking Some Underlying Issues
May 21Alcon (VTX:ALC) Seems To Use Debt Quite Sensibly
Apr 08Is It Too Late To Consider Buying Alcon Inc. (VTX:ALC)?
Mar 24
Unity VCS And PRECISION7 Launches Will Strengthen Position In Eye Care Market
Alcon's broad product pipeline and innovations in Surgical, Vision Care, and Ocular Health are positioned to propel revenue growth.Alcon Inc.'s (VTX:ALC) Share Price Matching Investor Opinion
Mar 12Alcon Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 28There's Been No Shortage Of Growth Recently For Alcon's (VTX:ALC) Returns On Capital
Feb 05We Ran A Stock Scan For Earnings Growth And Alcon (VTX:ALC) Passed With Ease
Jan 22Does Alcon (VTX:ALC) Have A Healthy Balance Sheet?
Dec 12Are Investors Undervaluing Alcon Inc. (VTX:ALC) By 28%?
Nov 27Shareholder Returns
| ALC | CH Medical Equipment | CH Market | |
|---|---|---|---|
| 7D | 5.9% | 4.9% | 3.1% |
| 1Y | -17.8% | -17.0% | 7.2% |
Return vs Industry: ALC underperformed the Swiss Medical Equipment industry which returned -15.7% over the past year.
Return vs Market: ALC underperformed the Swiss Market which returned 8.4% over the past year.
Price Volatility
| ALC volatility | |
|---|---|
| ALC Average Weekly Movement | 4.1% |
| Medical Equipment Industry Average Movement | 4.1% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in CH Market | 7.6% |
| 10% least volatile stocks in CH Market | 1.6% |
Stable Share Price: ALC has not had significant price volatility in the past 3 months compared to the Swiss market.
Volatility Over Time: ALC's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1945 | 25,000 | David Endicott | www.alcon.com |
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.
Alcon Inc. Fundamentals Summary
| ALC fundamental statistics | |
|---|---|
| Market cap | CHF 30.89b |
| Earnings (TTM) | CHF 828.90m |
| Revenue (TTM) | CHF 8.06b |
Is ALC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALC income statement (TTM) | |
|---|---|
| Revenue | US$10.19b |
| Cost of Revenue | US$4.53b |
| Gross Profit | US$5.66b |
| Other Expenses | US$4.61b |
| Earnings | US$1.05b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.13 |
| Gross Margin | 55.57% |
| Net Profit Margin | 10.28% |
| Debt/Equity Ratio | 21.4% |
How did ALC perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/13 10:48 |
| End of Day Share Price | 2025/11/13 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Alcon Inc. is covered by 57 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Argus Research Company |
| Jeffrey Johnson | Baird |
| null null | Baird |